InvestorsHub Logo
Followers 46
Posts 1362
Boards Moderated 0
Alias Born 08/09/2015

Re: LGL8054 post# 38220

Wednesday, 11/18/2015 10:06:14 AM

Wednesday, November 18, 2015 10:06:14 AM

Post# of 459506
Permission to move to a phase 3 is of great importance. Only about 33% of drugs in clinical trials make it. You can confirm this on the FDA website. With what many on this board know about the science behind Anavex drug therapy combined with moving forward to a larger study is very significant. All of this means that the odds of getting approval of Anavex 2-73 and/or the combination with another drug already approved by the FDA (Aricept) are much higher than ever before.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News